Guidelines for Acromegaly Management

Acromegaly

2006 • 1,122 citations

Criteria for Cure of Acromegaly: A Consensus Statement

2000 • 1,013 citations

Complications of Transsphenoidal Surgery: Results of a National Survey, Review of the Literature, and Personal Experience

1997 • 995 citations

Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant

2000 • 856 citations

Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly¹

1998 • 599 citations

Determinants of clinical outcome and survival in acromegaly

1994 • 573 citations

An audit of outcome of treatment in acromegaly

1993 • 476 citations

Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

1992 • 411 citations

Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients

1998 • 365 citations

Transsphenoidal Microsurgery for Growth Hormone-Secreting Pituitary Adenomas: Initial Outcome and Long-Term Results

1998 • 347 citations

Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly

1998 • 339 citations

Somatostatin Inhibits Insulin and Glucagon Secretion via Two Receptor Subtypes: An in Vitro Study of Pancreatic Islets from Somatostatin Receptor 2 Knockout Mice*

2000 • 316 citations

Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy

1998 • 286 citations

Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly

1998 • 285 citations

Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients

1988 • 265 citations

Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.

1997 • 259 citations

Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk

1993 • 248 citations

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

1995 • 246 citations

Octreotide as Primary Therapy for Acromegaly

1998 • 243 citations

Treatment of Acromegaly with Dopamine Agonists

1992 • 222 citations

Current Treatment Guidelines for Acromegaly¹

1998 • 215 citations

Effect of Octreotide Pretreatment on Surgical Outcome in Acromegaly

1997 • 214 citations

Surgical Management of Acromegaly

1992 • 208 citations

Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure

1996 • 200 citations

Hormonal and Metabolic Effects of Radiotherapy in Acromegaly: Long-Term Results in 128 Patients Followed in a Single Center

2000 • 199 citations

Pituitary Irradiation Is Ineffective in Normalizing Plasma Insulin-Like Growth Factor I in Patients with Acromegaly¹

1997 • 181 citations

Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon

1999 • 177 citations

Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide¹

1997 • 177 citations

Sandostatin LAR in Acromegalic Patients: Long Term Treatment

1997 • 174 citations

Radiosurgery for Pituitary Tumors and Craniopharyngiomas

1999 • 165 citations

Transsphenoidal Surgery for Acromegaly: Endocrinological Follow-up of 98 Patients

2001 • 164 citations

Increased Prevalence of Regurgitant Valvular Heart Disease in Acromegaly

2004 • 159 citations

Radiation Therapy of Acromegaly

1992 • 143 citations

Transsphenoidal Surgery for Acromegaly in Wales: Results Based on Stringent Criteria of Remission

2003 • 135 citations

Results of surgical treatment for growth hormone-secreting pituitary adenomas

1993 • 130 citations

Is the Acromegalic Cardiomyopathy Reversible? Effect of 5-Year Normalization of Growth Hormone and Insulin-Like Growth Factor I Levels on Cardiac Performance*

2001 • 124 citations

Octreotide Long-Acting Release (LAR)

1997 • 122 citations

Predictors of the Outcome of Surgical Treatment in Acromegaly and the Value of the Mean Growth Hormone Day Curve in Assessing Postoperative Disease Activity

2001 • 120 citations

Current Treatment Guidelines for Acromegaly

1998 • 119 citations

Growth Hormone Receptor Antagonist Therapy in Acromegalic Patients Resistant to Somatostatin Analogs*

2000 • 105 citations

Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide

1997 • 99 citations

Pituitary Irradiation Is Ineffective in Normalizing Plasma Insulin-Like Growth Factor I in Patients with Acromegaly

1997 • 99 citations

Transsphenoidal Microsurgery for Growth Hormone-Secreting Pituitary Adenomas: Initial Outcome and Long-Term Results

1998 • 96 citations

The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly

1995 • 89 citations

Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients

1998 • 86 citations

The Role of Pharmacotherapy in Perioperative Management of Patients with Acromegaly

2003 • 73 citations

Clinical results of long‐term slow‐release lanreotide treatment of acromegaly

1997 • 68 citations

Sandostatin LAR in Acromegalic Patients: Long Term Treatment

1997 • 62 citations

Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide

2000 • 55 citations

Effect of Octreotide Pretreatment on Surgical Outcome in Acromegaly

1997 • 53 citations

Megavoltage pituitary irradiation lowers but seldom leads to safe GH levels in acromegaly: a long-term follow-up study

1998 • 46 citations

Acromegaly: what constitutes optimal therapy?

1996 • 27 citations

Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal

1992 • 23 citations

Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide

2000 • 18 citations

Tight Control of Growth Hormone: An Attainable Outcome for Acromegaly Treatment

1998 • 17 citations

Acromegaly: what constitutes optimal therapy?

1996 • 12 citations

Deleted Work

1955 • 0 citations